The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Sondrel wins USD23 million contract

Tue, 27th Feb 2024 14:18

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Cloudbreak Discovery PLC - Vancouver, Canada-based natural resource project generator - Signs an exploration agreement for the acquisition of its proprietary database of lithium targets in Texas. Smackover Resources LLC, a wholly owned subsidiary of Lonestar Lithium Inc, has purchased the proprietary database with regional modelling and data compilation across eastern Texas from Cloudbreak. The terms include: 2.0 million shares in Lonestar; USD25,000 each time a Qualifying Transaction property is generated from the database; and 0.5% Royalty produced lithium on each Qualifying Transaction property. The areement is for three years. Interim Chief Executive Andrew Male says: "This Exploration Agreement is a good example of the type of transactions Cloudbreak has completed in the past and will continue to do with a sector of its asset base. It took considerable time and effort to compile this database and being able to sell this on to Lonestar demonstrates the possible valuation accretion by doing this type of business."

----------

United Oil & Gas PLC - Oil and gas company, focused on Egypt, the UK and Jamaica - Raises GBP1.0 million through oversubscribed placing of 457.5 million shares and 42.5 shares by way of a subscription. A total of 500.0 million shares will be issued through the fundraising, 76% of the company's issued share capital. Funds will be used to progress work in Jamaica and for administration costs.

----------

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Expands its data supply network, which it says will significantly increase the number of labs through which Diaceutics is sourcing data in Europe and will broaden the company's European data coverage. This data will accelerate the rollout of the DxRx Signal product in key EU markets of Germany, France, Italy, Spain and the UK. Jordan Clark, chief data officer of Diaceutics, comments: "This data will further endorse our position as a leading provider of data to biotech and pharma companies as they commercialize their products, find and deliver therapies to patients across multiple geographies."

----------

Crossword Cybersecurity PLC - London-based cybersecurity solutions provider - Launches Trillion HarVista. Says the Trillion HarVista tool allows enterprise security teams to search conversations on the dark web in a clean and sanitised environment. It "enables security teams, for the first time, to be able to identify the threats developing both from hacker discussions and shared compromised credential data all from a single interface, without the risk of searches on hostile websites being linked to your organisation."

----------

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Receives a first purchase order under the master services agreement with an unnamed "leading diagnostics company." The first purchase order, valued at around GBP60,000, has been received for an initial project to generate antibodies specifically for the client's use in diagnostic products. It is anticipated that further purchase orders will follow for additional and recurring projects. CEO Adrian Kinkaid says: "Reaching this agreement with a world class diagnostics provider positively reinforces the value to the wider commercial world of Fusion Antibodies' technologies and capabilities. In this case it is the generation of antibodies in diagnostics products. We look forward to establishing a long-term relationship with our new partner and providing them with assistance to generate better antibodies which are more manufacturable and can be rapidly deployed in clinical diagnostic products for the benefit patient well-being across the globe."

----------

Sondrel Holdings PLC - Reading, England-based semiconductor design services firm - Wins new design and supply contract for a next generation video processing chip with a total estimated value of USD23 million across the design, qualification and projected production life of the product. "The complex chip is to be used for high performance professional video streaming solutions. The company has entered into the master agreement with the customer and design work has commenced whilst the parties finalise negotiations to the exhibits to the agreement," it says. The initial contract value is for over USD9 million for the duration of the design and qualification phases and the work will be fully funded by the customer. CEO Graham Curren says: "This is a substantial design and supply contract for Sondrel and a demonstration of the group's ability to provide the most complex engineering expertise required for these next generation technologies. We're delighted to partner with one of the leading manufacturers in the high growth video streaming market, where the constant innovation and focus on efficiency is driving demand for complex chips like Sondrel's." Also reports that it has received four new orders in 2024 year to date for its design consulting services, engaging with two existing customers and two new customers. These contracts will generate a combined revenue of USD900,000 in the current financial year.

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
25 Feb 2019 11:56

Fusion Antibodies Guides For Revenue "Materially Below" Market Views

LONDON (Alliance News) - Fusion Antibodies PLC on Monday warned that annual revenue will be "materially below current market expectations" due to the uncertain timing of closure of were

Read more
25 Feb 2019 10:43

Fusion Antibodies dives as revenues falter

(Sharecast News) - Fusion Antibodies' shares plummeted on Monday after the company warned of failing revenues due to uncertainty surrounding the timing of "a number of potential substantial orders".

Read more
17 Dec 2018 14:51

Fusion Antibodies launches new 'RAMP' platform

(Sharecast News) - Pharmaceutical contract research organisation Fusion Antibodies launched its new 'Rational Affinity Maturation Platform' (RAMP) at the Antibody Engineering Conference in San Diego last week, it announced on Monday.

Read more
26 Nov 2018 10:39

Fusion Antibodies Interim Loss Widens On Increasing Competition

LONDON (Alliance News) - Fusion Antibodies PLC on Monday said that increasing competition, pricing pressures, and lower order levels have resulted in a substantial fall in revenue and a sharply of

Read more
26 Nov 2018 10:17

Fusion Antibodies sees losses widen throughout 'challenging' first half

(Sharecast News) - Pharmaceutical research outfit Fusion Antibodies saw losses widen sharply throughout the first half of its trading year after revenues more than halved.

Read more
24 Sep 2018 17:03

DIRECTOR DEALINGS: Fusion Antibodies Non-Executive Buys Shares

LONDON (Alliance News) - Fusion Antibodies PLC said Monday Non-Executive Director Timothy Watts bought shares worth GBP10,237 in the life sciences firm in a transaction last Thursday.Watts

Read more
16 Aug 2018 13:40

Fusion Antibodies Posts Solid Revenue Rise But Warns On Current Trade

LONDON (Alliance News) - Fusion Antibodies PLC on Thursday said it has delivered strong annual revenue growth in a year in which it joined the London Stock Exchange's AIM market.The in

Read more
16 Aug 2018 08:10

Fusion Antibodies gets dragged to a loss as non-recurring items skyrocket

(Sharecast News) - Contract researcher Fusion Antibodies saw revenues hit £2.7m in its last trading year but was unable to chalk up a profit.

Read more
16 Aug 2018 08:10

Fusion Antibodies gets dragged to a loss as non-recurring items skyrocket

(Sharecast News) - Contract researcher Fusion Antibodies saw revenues hit £2.7m in its last trading year but was unable to chalk up a profit.

Read more
13 Aug 2018 10:31

WINNERS & LOSERS SUMMARY: Chemring Says Fatal Accident To Hurt Profit

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------BAE up 0.8%. a

Read more
13 Aug 2018 10:26

Fusion Antibodies Shares Fall 30% After Profit Warning For New Year

LONDON (Alliance News) - Shares fell in Fusion Antibodies PLC on Monday as it reported that trading in its current financial year to date has been slower than expected, due to increase competition

Read more
13 Aug 2018 08:27

Fusion Antibodies shares tumble following downbeat outlook

(Sharecast News) - Fusion Antibodies shares crashed on Monday morning after the Belfast-based researcher revealed that year-to-date trading had been "slower than anticipated".

Read more
24 May 2018 14:59

Fusion Antibodies Receives Up To GBP213,000 Grant From Invest NI

LONDON (Alliance News) - Fusion Antibodies PLC said Thursday it received additional grants from regional business development agency Invest Northern Ireland of up to GBP213,000.The company

Read more
4 Apr 2018 08:00

Qatar's market manipulation fears fuelled by "abnormal" derivative moves-bank CEO

* Qatar c. bank probing market manipulation during Gulf standoff * Qatar's top bank helping central bank with probe * QNB says has cash

Read more
29 Mar 2018 14:03

MIDEAST STOCKS-Saudi retreats after winning FTSE emerging status, rest of region strong

* Saudi market had surged before FTSE decision * Profit-taking is moderate, little downside seen * Other Gulf bourses may get some relief from fund outflows * blue chips climb

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.